XML 58 R46.htm IDEA: XBRL DOCUMENT v3.24.3
BAQSIMI Acquisition (Narrative) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2023
Apr. 21, 2023
Jun. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Asset Acquisition [Line Items]            
Proceeds from Lines of Credit         $ 13,565  
BAQSIMI product rights            
Asset Acquisition [Line Items]            
Cash payment     $ 129,000      
Contingent consideration   $ 575,000        
Deferred payment including accrued interest $ 129,000          
Interest expense accretion period 1 year          
Interest expense recognized related to accretion of deferred payment       $ 1,800 $ 3,600 $ 1,800
BAQSIMI product rights | Maximum [Member] | Manufacturing Services Agreement            
Asset Acquisition [Line Items]            
Agreement term 18 months          
BAQSIMI product rights | Maximum [Member] | Transition Services Agreement            
Asset Acquisition [Line Items]            
Agreement term 18 months